TMC Life Sciences Berhad reported earnings results for the fourth quarter and full year ended June 30, 2023. For the fourth quarter, the company reported sales was MYR 84.65 million compared to MYR 70.8 million a year ago. Net income was MYR 13.25 million compared to MYR 23.47 million a year ago. Basic earnings per share from continuing operations was MYR 0.0076 compared to MYR 0.0135 a year ago. Diluted earnings per share from continuing operations was MYR 0.0076 compared to MYR 0.0135 a year ago.
For the full year, sales was MYR 311.44 million compared to MYR 243.77 million a year ago. Net income was MYR 39.26 million compared to MYR 41.39 million a year ago. Basic earnings per share from continuing operations was MYR 0.0225 compared to MYR 0.0238 a year ago. Diluted earnings per share from continuing operations was MYR 0.0225 compared to MYR 0.0238 a year ago.